Biosensors International Group
Biosensors International Group
Biosensors International Group, Ltd
Biosensors International develops, manufactures and markets pioneering interventional cardiology devices. The BioMatrix™ DES family features Biolimus A9™ (BA9™), a highly lipophilic anti-restenotic drug designed for cardiovascular stent technologies patented by Biosensors, combined in a unique abluminal biodegradable polymer coating. BioMatrix Alp
Ansprechpersonen
Warum ist hier denn nichts zu sehen?
Vielleicht klappt's wieder, wenn Du auf "Aktualisieren" klickst.